FDA warned Sammy's Milk that it markets goat milk toddler formula as infant formula without required notice and falsely claimed Cronobacter testing.
What happened
FDA inspected the company's contract manufacturer (the inspection dates and location are blacked out in the letter provided) and also reviewed the sammysmilk.com website and its Instagram, Facebook and X pages between February and August 2024. FDA found statements and images presenting Sammy's Milk Goat Milk Toddler Formula as suitable for infants, including claims that it meets every FDA infant formula requirement, even though the company never filed the required premarket notice for a new infant formula. FDA also found a website statement that every batch is tested for Cronobacter (a bacteria that can harm infants), while the contract manufacturer said it had never tested for it. The company had already recalled product distributed February 1 to April 18, 2024, and issued an April 18, 2024 press release, but some infant-directed images and comments remained online.
What FDA found
The company presented its toddler formula as an infant formula, which under the law makes it an infant formula subject to infant formula rules.
Section 201(z) of the Act [21 U.S.C. § 321(z)]The product is a new infant formula because the company had not made infant formula before, so it needed to submit required information to FDA before selling it.
Section 412(c)(2) and 412(d)(1) of the Act [21 U.S.C. § 350a(c)(2), (d)(1)]The company sold the product without giving FDA the required notice at least 90 days before marketing.
Section 412(c)(1)(B) of the Act [21 U.S.C. § 350a(c)(1)(B)]; prohibited act under Section 301(s) [21 U.S.C. § 331(s)]The website claimed every batch is tested for Cronobacter, but the contract manufacturer said no such testing was ever done, so the labeling was false or misleading.
Section 403(a) of the Act [21 U.S.C. § 343(a)]Images of young infants and company replies to customers on social media still present the toddler formula as intended for infants.
Section 403(a) of the Act [21 U.S.C. § 343(a)]
What FDA wants
FDA asks the company to write to FDA within 15 working days describing the specific steps taken to fix each violation and prevent it from happening again, with supporting documents, and to explain any delay and when the work will be finished.
Who should pay attention
- infant formula and toddler formula brands and sellers
- contract manufacturers that make powdered nutritional products
- retailers and online marketplaces selling infant feeding products
This is a summary. Read the original letter on fda.gov.